We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Chelsea Germak has been assisting clients through the H1B Visa process since 2022.

As of 2022, Chelsea Germak has succesfully submitted and recieved certification for 1,030 cases.

Chelsea Germak is located in Matawan, NJ, and has represented 56 employers for the H1B Visa Process

1,048
Cases Handled
1,030
Cases Certified
98.28%
Approval

Cases Handled by Chelsea Germak

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23117-972046 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023
I-200-23114-958777 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023
I-200-22318-585936 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023
I-200-22132-166626 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2022
I-200-22132-164825 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2022
I-200-22089-022404 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2022
I-200-21337-743068 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Merck Sharp Dohme Corp 2022
I-200-21314-698263 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2022
I-200-21097-204854 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2021
I-200-21091-190262 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2021